Elicio Therapeutics Files Proxy Statement for Nov. 7 Meeting

TL;DR

Elicio Proxy filed for Nov 7th meeting - vote your shares!

AI Summary

Elicio Therapeutics, Inc. filed its definitive proxy statement on September 27, 2024, for its annual meeting of stockholders scheduled for November 7, 2024. The company, formerly known as Angion Biomedica Corp., is seeking shareholder approval for various matters at this meeting. The filing is a standard DEF 14A, indicating it's a proxy statement for soliciting votes.

Why It Matters

This filing is crucial for shareholders as it outlines the proposals they will vote on, including director elections and other corporate matters, directly impacting the company's governance and future direction.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing for an annual meeting, not indicating any immediate financial distress or unusual corporate activity.

Key Numbers

• 001-39990 — SEC File Number (Identifies the company's registration with the SEC.)

Key Players & Entities

• Elicio Therapeutics, Inc. (company) — Registrant
• Angion Biomedica Corp. (company) — Former company name
• 20241107 (date) — Annual meeting date
• 20240927 (date) — Filing date

FAQ

Key Financial Figures

• $12,500 — ces, we will pay a fee of approximately $12,500 plus expenses. What does it mean if I r

Filing Documents

• ny20035898x2_def14a.htm (DEF 14A) — 646KB
• logo_elicio.jpg (GRAPHIC) — 27KB
• ny20035898x2_pc01.jpg (GRAPHIC) — 846KB
• ny20035898x2_pc02.jpg (GRAPHIC) — 1046KB
• 0001140361-24-042209.txt ( ) — 3291KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT     23 EXECUTIVE OFFICERS OF THE COMPANY     25

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION     26 2023 Summary Compensation Table     26 Outstanding Equity Awards at 2023 Fiscal Year End     30 Director Compensation     31 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE     35 Related Person Transactions Policy and Procedures     35 Certain Related Person Transactions     35 Indemnification     37 HOUSEHOLDING OF PROXY MATERIALS     38 OTHER MATTERS     38         ii TABLE OF CONTENTS QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING How do I attend the Annual Meeting? We have determined that the Annual Meeting will be held in a virtual meeting format only, with no physical in-person meeting. We have designed our virtual format to enhance, rather than constrain stockholder access, participation and communication. The Annual Meeting will be held through a live webcast. In order to attend, you must pre-register at www.viewproxy.com/ELTX/2024. You will not be able to attend the Annual Meeting in person. If you attend the Annual Meeting online, you will be able to vote and submit questions during the meeting. You need not attend the Annual Meeting in order to vote. You are entitled to attend the Annual Meeting if you were a stockholder as of the close of business on September 11, 2024, the record date, or hold a valid proxy for the Annual Meeting. To be admitted to the Annual Meeting, use your unique link and password that was provided upon registration at www.viewproxy.com/ELTX/2024. If you are a beneficial stockholder and plan on voting at the meeting, you should contact the bank, broker, or other institution where you hold your account well in advance of the Annual Meeting if you have questions about obtaining your legal proxy. Whether or not you participate in the Annual Meeting, it is import

View Full Filing

View this DEF 14A filing on SEC EDGAR